空气净化器还能降压!?Hypertension杂志分析

2020-06-04 朱朱 中国循环杂志

6月1日,Hypertension杂志在线发表的一项系统综述和Meta分析表明,家庭用细微颗粒空气过滤器可能有助于降低血压。

61日,Hypertension杂志在线发表的一项系统综述和Meta分析表明,家庭用细微颗粒空气过滤器可能有助于降低血压。
 
该分析一共纳入10项随机对照研究,均观察不吸烟者(一共604人)在无烟家庭中使用真的或假的空气净化器时血压的变化。
 
结果发现,平均使用空气净化器13.5天后,这些不吸烟的人平均收缩压大约降低了4 mmHg,舒张压略有下降(-0.95 mmHg),但没有达到统计学差异。
 
亚组分析表明,在不同年龄、细颗粒物暴露水平、研究时间、心肺危险因素、用药情况等条件下,空气净化器均有助于降低收缩压。
 
研究者指出,该分析得出的结果是比较显著的,因为从人群层面来看,血压即便小幅降低,也可导致心血管病发生率和死亡率明显下降。
 
据估计,人群平均收缩压降低5 mmHg,因中风死亡、发生冠心病、全因死亡的风险分别会降低14%9%7%
 
在该Meta分析中,应用空气净化器后短期内收缩压即可下降约4 mmHg,长期持续应用可能会带来明显的健康获益。
 
他们表示,空气净化器是一种价格较便宜、且购买方便的设备,可能是一种有效的心脏保护干预手段,医生可考虑推荐大众尤其高危人群使用空气净化器。
 
不过,研究者表示,由于这些研究的设计存在差别,因此该分析结果需要其他研究来证实。另外,使用个别空气净化器带来的降压获益需要更好地进行量化。
 
其中9项研究的研究时间平均为9天,其余1项研究随访时间长达1年。
 
在所有研究中,应用空气净化器后,室内PM2.5浓度降低了56%
 
来源:Effects of Home Particulate Air Filtration on Blood Pressure: A Systematic Review. Hypertension, 1 Jun 2020

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1728528, encodeId=816f1e28528b0, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Sep 24 15:21:43 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039194, encodeId=678a203919487, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Sun Apr 04 05:21:43 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292075, encodeId=021e12920e55f, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Sat Jun 06 06:21:43 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501476, encodeId=b2c015014e677, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Sat Jun 06 06:21:43 CST 2020, time=2020-06-06, status=1, ipAttribution=)]
    2020-09-24 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1728528, encodeId=816f1e28528b0, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Sep 24 15:21:43 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039194, encodeId=678a203919487, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Sun Apr 04 05:21:43 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292075, encodeId=021e12920e55f, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Sat Jun 06 06:21:43 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501476, encodeId=b2c015014e677, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Sat Jun 06 06:21:43 CST 2020, time=2020-06-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1728528, encodeId=816f1e28528b0, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Sep 24 15:21:43 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039194, encodeId=678a203919487, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Sun Apr 04 05:21:43 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292075, encodeId=021e12920e55f, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Sat Jun 06 06:21:43 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501476, encodeId=b2c015014e677, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Sat Jun 06 06:21:43 CST 2020, time=2020-06-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1728528, encodeId=816f1e28528b0, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Sep 24 15:21:43 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039194, encodeId=678a203919487, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Sun Apr 04 05:21:43 CST 2021, time=2021-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292075, encodeId=021e12920e55f, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Sat Jun 06 06:21:43 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501476, encodeId=b2c015014e677, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Sat Jun 06 06:21:43 CST 2020, time=2020-06-06, status=1, ipAttribution=)]

相关资讯

JAHA:两类降糖新药还有降压功效!北大人民医院纪立农等Meta分析称,通过减重而非降糖发挥此作用

4月4日,武汉大学人民医院联合多家医院学者发表的一项多中心回顾性队列研究显示,34例处于潜伏期即无症状新冠病毒感染者在接受择期手术后,很快全部发病,其中病情进展至需要住重症监护室(ICU)治疗的患者占

Stroke:脑卒中后降压处方的差异

由此可见,卒中后开出降压药的处方因医院而异,并取决于患者因素,包括年龄、性别、卒中严重程度和合并症。

Lancet: 近500万高血压数据分析:老药使心血管事件多减少15%

指南建议初始降压治疗可使用的药物包括利尿剂、血管紧张素转化酶抑制剂(ACEI)、血管紧张素Ⅱ受体阻滞剂(ARB)、钙拮抗剂等。但这些药物通过降压,预防心脑血管并发症的效果有差别吗?

Circulation:白藜芦醇是通过诱导蛋白质氧化来降血压,而非抗氧化

白藜芦醇是一种天然多酚,具有促进健康和限制疾病的特性,引起了人们的极大兴趣。白藜芦醇的多酚环使它能够与有害的氧化剂发生反应并解毒。白藜芦醇的保护作用通常被归因于它的抗氧化活性,但近期研究人员发现,事实并非如此。研究人员在孤立的大鼠主动脉平滑肌细胞中评估白藜芦醇氧化cGMP-依赖性PKG1α(蛋白激酶1α)的能力,通过体外实验、质谱和电子顺磁共振解析其作用机制。用血管紧张素II诱导野生型和C42S敲

JAMA Netw Open:“中国急性缺血性脑卒中降压研究”全新分析:高血压患者中风后尽早启动降压有获益

近年来,对于急性缺血性中风发作后降压治疗对临床预后的影响,大多数临床研究得出了中性的结果。

大气PM2.5小幅降低的降压效果与限盐类似!阜外医院郑昕等研究称

阜外医院郑昕等发表华中地区大样本的典型性人群横断面调查数据发现,PM2.5 长期暴露会导致血压升高,尤其是对收缩压的影响最大。该研究显示,PM2.5 每增高10 μg/m3,收缩压、舒张压、脉压和平均动脉压分别增加2.47 mmHg、0.69 mmHg、1.79 mmHg 和1.28 mmHg。虽然PM2.5 长期暴露浓度每增加10 μg/m3,个体水平上血压仅上升1~2 mmHg。但研究者认为,